Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Plos Biology
|
October 20, 2021
AI delivers Michaelis constants as fuel for genome-scale metabolic models
Albert A Antolin, Marta Cascante
Expert Opinion on Drug Discovery
|
July 15, 2024
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa, Albert A Antolin
British Journal of Clinical Pharmacology
|
April 30, 2026
The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom
Simrit Dhillon, Albert A Antolin, Alan M Jones
Future Medicinal Chemistry
|
November 29, 2019
Public resources for chemical probes: the journey so far and the road ahead
Albert A Antolin, Paul Workman, Bissan Al-Lazikani
Current Pharmaceutical Design
|
September 28, 2016
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Albert A Antolin, Paul Workman, Jordi Mestres, et al.
Cell Chemical Biology
|
October 5, 2023
A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis
Huabin Hu, Amelie Tjaden, Stefan Knapp, et al.
British Journal of Clinical Pharmacology
|
July 30, 2021
Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale
Daranjit Sandhu, Albert A Antolin, Anthony R Cox, et al.
Cell Chemical Biology
|
June 2, 2021
Evolution of kinase polypharmacology across HSP90 drug discovery
Albert A Antolin, Paul A Clarke, Ian Collins, et al.
European Journal of Medicinal Chemistry
|
January 31, 2026
Charting the evolving landscape of kinase hinge-binding chemotypes beyond flatland: a systematic analysis and opportunities for sp<sup>3</sup>-rich binders
Shangde Liu, Tianlei Han, Zhenyu Zhang, et al.
Journal of Chemical Information and Modeling
|
September 18, 2024
Combining Data-Driven and Structure-Based Approaches in Designing Dual PARP1-BRD4 Inhibitors for Breast Cancer Treatment
Bo Feng, Hui Yu, Xu Dong, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Plos Biology
|
October 20, 2021
AI delivers Michaelis constants as fuel for genome-scale metabolic models
Albert A Antolin, Marta Cascante
Expert Opinion on Drug Discovery
|
July 15, 2024
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa, Albert A Antolin
British Journal of Clinical Pharmacology
|
April 30, 2026
The interplay between molecular architecture, pharmacology, and suspected adverse drug reactions associated with nonsteroidal androgen antagonists in the United Kingdom
Simrit Dhillon, Albert A Antolin, Alan M Jones
Future Medicinal Chemistry
|
November 29, 2019
Public resources for chemical probes: the journey so far and the road ahead
Albert A Antolin, Paul Workman, Bissan Al-Lazikani
Current Pharmaceutical Design
|
September 28, 2016
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Albert A Antolin, Paul Workman, Jordi Mestres, et al.
Cell Chemical Biology
|
October 5, 2023
A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis
Huabin Hu, Amelie Tjaden, Stefan Knapp, et al.
British Journal of Clinical Pharmacology
|
July 30, 2021
Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale
Daranjit Sandhu, Albert A Antolin, Anthony R Cox, et al.
Cell Chemical Biology
|
June 2, 2021
Evolution of kinase polypharmacology across HSP90 drug discovery
Albert A Antolin, Paul A Clarke, Ian Collins, et al.
European Journal of Medicinal Chemistry
|
January 31, 2026
Charting the evolving landscape of kinase hinge-binding chemotypes beyond flatland: a systematic analysis and opportunities for sp<sup>3</sup>-rich binders
Shangde Liu, Tianlei Han, Zhenyu Zhang, et al.
Journal of Chemical Information and Modeling
|
September 18, 2024
Combining Data-Driven and Structure-Based Approaches in Designing Dual PARP1-BRD4 Inhibitors for Breast Cancer Treatment
Bo Feng, Hui Yu, Xu Dong, et al.
Page
of 3